Home | Site map | Elsevier websites | Alerts
Elsevier
Product information search
Search all Elsevier sites
Search
Advanced Product Search
Go to Elsevier home page
SiteStat.jsp
NEUROTOXICOLOGY AND TERATOLOGY
Sponsored by the Behavioral Toxicology Society and the Neurobehavioral Teratology Society

Guide for Authors

Neurotoxicology and Teratology publishes only peer-reviewed original reports of systematic studies in the areas of neurotoxicology and developmental neurotoxicology in which the primary emphasis and theoretical context are on the nervous system and/or behavior. Brief Communications describe a new method, technique, or apparatus and results of experiments which can be reported briefly with limited figures and tables. Invited Reviews provide a timely update on selected aspects of a scientific field undergoing rapid change or that present special methodological or interpretive problems. Full-length review articles are also published. A limited number of relevant theoretical articles, results of symposia, and reviews with open peer commentaries will also be published. Articles will be published in English. All article types are peer-reviewed. Submitted papers may not be simultaneously under consideration for publication elsewhere.

Submission of Manuscripts. It is a condition of publication that all manuscripts must be submitted in English to Neurotoxicology and Teratology's submission and review website, External link http://ees.elsevier.com/ntt. Authors are requested to transmit the text and art of the manuscript in electronic form to this address. Each manuscript must also be accompanied by a cover letter outlining the basic findings of the paper and their significance. Minimal exceptions will be exercised. The Editor welcomes submissions by the authors of the names and addresses of up to five individuals who could expertly review the paper, and who are not from the same institutions as the authors. The Editor reserves the right to use these or other reviewers.

Conflict of Interest and Source of Funding. A conflict of interest exists when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's actions. All submissions to Neurotoxicology and Teratology must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. Neurotoxicology and Teratology may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the article.

Conflict of Interest Statements for Authors. At the end of the text, under a subheading "Conflict of Interest Statement," all authors must disclose any financial, personal, or their relationships with other people or organizations within 3 years of beginning the work submitted that could inappropriately influence the work submitted. Examples of conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants. If there are no conflicts of interest, authors should state that there are none. Investigators should disclose potential conflicts to participants in clinical trials and other studies and should state in the manuscript whether they have done so. Neurotoxicology and Teratology may decide not to publish on the basis of a declared conflict, such as the financial interest of an author in a company (or its competitors) that makes a product discussed in the paper. Signed copies of the Neurotoxicology and Teratology Conflict of Interest policy form are required upon submission. The Conflict of Interest policy form can be downloaded here. In order to minimize delays, we strongly advise that the signed copies of these statements are prepared before you submit your manuscript.

Role of the Funding Source. All sources of funding should be declared as an acknowledgment at the end of the text. Authors must also describe the role of the study sponsor(s), if any, in a study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the study sponsor(s) had no such involvement, the authors should so state.

US National Institutes of Health (NIH) voluntary posting/''Public Access Policy''. Elsevier facilitates author posting in connection with the voluntary posting request of the NIH (referred to as the NIH "Public Access Policy", see http://publicaccess.nih.gov/) by submitting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, immediately after final publication. Please e-mail us at NIHauthorrequest@elsevier.com that your work has received NIH funding (with the NIH grant/project number(s), as well as name and e-mail address of the Principal Investigator(s)) and that you intend to respond to the NIH request. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for public access posting 12 months after the final publication date. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly to PubMed Central, and any such posting is prohibited (although Elsevier will not request that manuscripts authored and posted by US government employees should be taken down from PubMed Central). Individual modifications to this general policy may apply to some Elsevier journals and its society publishing partners.

Language Polishing. Authors who require information about language editing and copyediting services pre- and post-submission please visit External link http://www.elsevier.com/locate/languagepolishing or contact authorsupport@elsevier.com for more information. Please note doi:10.1016/S0892-0362(06)00024-9 Neurotoxicology and Teratology 28 (2006) 162 - 164 www.elsevier.com/locate/neutera Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please refer to our Terms & Conditions (External link http://www.elsevier.com/locate/termsandconditions).

Preparation of Supplementary Material

Elsevier now accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish large table sets, supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect (External link http://www.sciencedirect.com). In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. The supplementary material should be submitted under ""Supplementary Material" when attaching your files at submission. For more detailed instructions please visit our artwork instruction pages at External link http://www.elsevier.com/artworkinstructions.

STYLE OF MANUSCRIPT

General Form.(1) The title page should contain: title of paper; author(s); laboratory or institution of origin with city, state, zip code, and country; complete address for mailing proofs, including telephone and FAX numbers, and e-mail address. (2) References, footnotes, and legends for illustrations should be typed on separate sheets, double spaced. (3) All dimensions and measurements must be specified in the metric system. Standard nomenclature, abbreviations and symbols, as specified by Royal Society Conference of Editors. Metrication in Scientific Journals, Am Scient 56 (1968) 159-164, should be used throughout. (4) Italics should not be used for the purpose of emphasis.

Title. The title should not be longer than 85 characters, including spaces between words.

Length of Paper. The editors insist upon clear, concise statement of facts and conclusions. Fragmentation of material into numerous short reports is discouraged. There is no page or word limitation on manuscript length.

Abstract. Each paper submitted must be accompanied by an abstract, which should be around 200 words and must be suitable for use by abstracting services. A list of 3-6 words or short phrases suitable for indexing terms should be typed at the bottom of the abstract page accompanying the manuscript. These terms will be printed with the paper at the end of the abstract.

Headings. All headings should be numbered according to the following examples:

1. Introduction
2. Methods
3. Results
3.1 Maternal variables
3.1.1. Pregnancy rate
3.1.2. Maternal weight gain
3.2. Fetal variables
4. Discussion

Drugs. Proprietary (trademarked) names should be capitalized. The chemical name should precede the trade, popular name, or abbreviation of a drug the first time it occurs.

Footnotes. Footnotes that connect authors with their affiliations should be provided as superscript lower-case letters (a,b,c, etc.) and should be given in alphabetical order. If senior author is not to receive reprint requests, a footnote should be given to designate to whom requests should be sent. Text footnotes should not be used; the material should be incorporated into the text. Table footnotes: see Table (b)

References. Literature cited should be prepared according to the Numbered/Alphabetized style of the CBE. References should be cited by number, in brackets, within the text (only one reference to a number) and listed in alphabetical order (double spaced) on a separate sheet at the end of the manuscript. Do not recite names of authors within the text. Journal citations in the reference list should contain the following: (a) initials and surnames of all authors (initials precede surname); (b) title of article; (c) journal title abbreviated as listed in the List of Journals Indexed in Index Medicus; (d) volume, year, and inclusive pages. Example:

[1]R.R. Holson, B. Pearce, Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species, Neurotoxicol Teratol 14 (1992) 221-228.

Book references should be in the following order: author, title, publisher, city of publication, year, and pages. Examples:

[1]R.E. Kirk, Experimental Design: Procedures for the Behavioral Sciences, Third Edition, Brooks/Cole Publishing Company, Pacific Grove, CA, 1995.

[2]M.G. Paule, J. Adams, Interspecies comparison of the evaluation of cognitive developmental effects of neurotoxicants in primates, in: L.W. Chang (Ed.), Principles of Neurotoxicology, Marcel Dekker, Inc., New York, 1994, pp. 713-731.

Figures. Each figure should be in one of the following preferred formats: Tiff, JPEG, PDF, and EPS. Please refer to External link http://www.elsvier.com/artworkinstructions for detailed instructions on preparing electronic artwork.

Tables.(a) Each table should bear a short descriptive title and should also be typed on separate sheets; explanatory matter should be in footnotes, not as part of the title. (b) Table footnotes should be indicated in the body of the table in order of their appearance with superscript, lower-case letters (a,b,c etc.). Footnotes pertaining to statistical information should be indicated with asterisks (*P , 0.01, **P , 0.001, etc.). (c) Tables must not duplicate material in text or illustrations. (d) Vertical rules should be omitted. (e) Short or abbreviated column heads should be used. (f) Statistical measures of variation, S.D., S.E., etc., should be identified. (g) Analysis of Variance tables should not be submitted but significant F's should be incorporated where appropriate within the text. The appropriate form for reporting F value is: F(11, 20)= 3.05, p ⟨⟩ 0.01.

Formulas and Equations. Structural chemical formulas, process flowdiagrams, and complicated mathematical expressions should be kept to a minimum. usually chemical formulas and flow-diagrams should be drawn in India ink for reproduction as line cuts. All subscripts, superscripts, Greek letters, and unusual characters must be clearly identified.

Anesthesia. In describing surgical procedures on animals, the type and dosage of the anesthetic agent should be specified. Curarizing agents are not anesthetics; if these were used, evidence must be provided that anesthesia of suitable grade and duration was employed.

Copyright. Publications are copyrighted for the protection of the authors and the publisher. A Transfer of Copyright Agreement will be sent to the author who submits the manuscript. The form must be completed and returned to the publisher before the article can be published.

Proofs and Reprints. One set of proofs of accepted manuscripts will be sent to the corresponding author. No alteration of the substance of the text, tables or figures will be allowed at this stage. Corrected proofs should be returned to the publisher within two days of receipt. Twenty-five reprints are provided free of charge, and additional copies (minimum 100) can be ordered at prices shown on the price list accompanying the Reprint Order Form which will be sent with the proofs. Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.

US National Institutes of Health (NIH) voluntary posting (" Public Access") policy.
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com ) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.

Author enquiries. For enquiries relating to the submission of articles, please visit the journal home page at External link http://www.elsevier.com. This website also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided when an article is accepted for publication.Authors of Neurotoxicology and Teratology please note: there is no page charge for this journal.
Printer-friendly version   Printer-friendly version
 Home | Site map | Privacy policy | Terms and Conditions | Feedback | A Reed Elsevier company
 Copyright © 2008 Elsevier B.V. All rights reserved.